Group One Trading’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-11,300
| Closed | -$66K | – | 8276 |
|
|
2022
Q4 | $66K | Sell |
11,300
-5,600
| -33% | -$29.4K | ﹤0.01% | 4791 |
|
|
2022
Q3 | $113K | Buy |
16,900
+4,800
| +40% | +$29.1K | ﹤0.01% | 4668 |
|
|
2022
Q2 | $51K | Buy |
12,100
+11,100
| +1,110% | +$43.9K | ﹤0.01% | 5541 |
|
|
2022
Q1 | $3K | Sell |
1,000
-1,000
| -50% | -$3.17K | ﹤0.01% | 7681 |
|
|
2021
Q4 | $6K | Sell |
2,000
-7,600
| -79% | -$25.3K | ﹤0.01% | 7609 |
|
|
2021
Q3 | $31K | Sell |
9,600
-4,000
| -29% | -$14K | ﹤0.01% | 6908 |
|
|
2021
Q2 | $57K | Sell |
13,600
-22,400
| -62% | -$94.8K | ﹤0.01% | 6463 |
|
|
2021
Q1 | $180K | Buy |
36,000
+33,800
| +1,536% | +$273K | ﹤0.01% | 5129 |
|
|
2020
Q4 | $28K | Buy |
2,200
+1,600
| +267% | +$18.2K | ﹤0.01% | 5340 |
|
|
2020
Q3 | $6K | Sell |
600
-500
| -45% | -$4.93K | ﹤0.01% | 5604 |
|
|
2020
Q2 | $11K | Sell |
1,100
-800
| -42% | -$7.67K | ﹤0.01% | 5102 |
|
|
2020
Q1 | $17K | Sell |
1,900
-3,400
| -64% | -$33.5K | ﹤0.01% | 4329 |
|
|
2019
Q4 | $49K | Buy |
5,300
+5,000
| +1,667% | +$35.4K | ﹤0.01% | 4015 |
|
|
2019
Q3 | $2K | Buy |
+300
| New | +$3.18K | ﹤0.01% | 4942 |
|
|
2019
Q2 | – | Sell |
-2,600
| Closed | -$31K | – | 5551 |
|
|
2019
Q1 | $31K | Sell |
2,600
-11,400
| -81% | -$168K | ﹤0.01% | 3834 |
|
|
2018
Q4 | $176K | Buy |
14,000
+13,800
| +6,900% | +$191K | ﹤0.01% | 2785 |
|
|
2018
Q3 | $3K | Sell |
200
-7,600
| -97% | -$120K | ﹤0.01% | 4983 |
|
|
2018
Q2 | $131K | Buy |
7,800
+3,900
| +100% | +$75.7K | ﹤0.01% | 3381 |
|
|
2018
Q1 | $89K | Sell |
3,900
-34,500
| -90% | -$767K | ﹤0.01% | 3318 |
|
|
2017
Q4 | $993K | Buy |
38,400
+29,800
| +347% | +$600K | 0.01% | 1706 |
|
|
2017
Q3 | $127K | Buy |
8,600
+700
| +9% | +$10.2K | ﹤0.01% | 3072 |
|
|
2017
Q2 | $110K | Sell |
7,900
-7,100
| -47% | -$105K | ﹤0.01% | 3048 |
|
|
2017
Q1 | $256K | Buy |
+15,000
| New | +$180K | ﹤0.01% | 2355 |
|
|
2016
Q3 | – | Sell |
-1,500
| Closed | -$17K | – | 5021 |
|
|
2016
Q2 | $17K | Buy |
1,500
+200
| +15% | +$2.55K | ﹤0.01% | 3876 |
|
|
2016
Q1 | $18K | Buy |
1,300
+1,200
| +1,200% | +$17.3K | ﹤0.01% | 3803 |
|
|
2015
Q4 | $2K | Buy |
+100
| New | +$2.17K | ﹤0.01% | 4552 |
|
Group One Trading's CNCE Position: Q1 2023 in Review
Group One Trading sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 1,891 shares — an estimated $11K sold.
Group One Trading first reported a position in CNCE in Q3 2015 and held it in 23 quarters. The position peaked at $399K in Q2 2017. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.
- Group One Trading reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Group One Trading sold 1,891 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $11K.
- Group One Trading first reported a position in Concert Pharmaceuticals, Inc. in Q3 2015 and held it in 23 quarters.
- Group One Trading's Concert Pharmaceuticals, Inc. position peaked at $399K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.
Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.